Trial Details
TERMINATEDBasic Information
| Clinical ID | c1206 |
|---|---|
| Identifier | NCT03298022 |
| Trial Title | Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: ALTB-168 |
Participant Information
| Sponsor | AltruBio Inc. |
|---|---|
| City | Little Rock |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-05-04 |
|---|---|
| Primary Completion Date | 2020-04-06 |
| Completion Date | 2020-06-01 |